Treatment of Transmissible Spongiform Encephalopathy by Intraventricular Drug Infusion in Animal Models

Medicine and Dentistry

• Pentosan Polysulfate 100%
• Infusion 66%
• Brain 66%
• Therapeutic Procedure 50%
• Transmissible Spongiform Encephalopathy 50%
• Combination Therapy 33%
• Drug Megadose 33%
• Infection 33%
• Incubation Time 33%
• Antimalarial Agent 33%
• Hemisphere 33%
• Drug Infusion 33%
• Adverse Event 16%
• Transgenic Mouse 16%
• Human 16%
• Therapy Effect 16%
• Contralateral 16%
• Intracerebroventricular Drug Administration 16%
• Target Organ 16%
• Mepacrine 16%
• Prion Protein 16%
• Cannula 16%
• Hematoma 16%
• Amphotericin B 16%
• Scrapie Agent 16%
• Catastrophic Illness 16%

Neuroscience

• Pentosan Polysulfate 100%
• Transmissible Spongiform Encephalopathies 50%
• Adverse Effect 16%
• Prion Protein 16%
• Hematoma 16%
• Amphotericin B 16%
• Scrapie 16%